Results 171 to 180 of about 4,477 (231)

Combined Biomarker Panel of Presepsin, HE4, and Oxygenation Index for Sepsis Diagnosis and Prognosis in Intensive Care Unit Patients. [PDF]

J Inflamm Res
Luo J, An S, Liao X, Wu J, Li L.
europepmc   +1 more source

Serum miR-200c-3p and miR-6134 as diagnostic biomarkers for epithelial ovarian cancer. [PDF]

Discov Oncol
Kawahara R, Nishio E, Iwata A, Nishizawa H, Yamamoto N, Fujii T.   +5 more
europepmc   +1 more source

Serum Levels of CA125 and HE4 as a Tool for Predicting Regional Lymph Node Metastatic Involvement in Endometrial Carcinoma. [PDF]

Cancers (Basel)
Crha T, Ovesná P, Weinberger V, Felsinger M, Babjak B, Valík D, Hausnerová J, Minář L.   +7 more
europepmc   +1 more source

The role of ITGA3 expression in predicting liver metastasis in patients with epithelial ovarian cancer. [PDF]

BMC Med Genomics
Zhu K, Cheng T, Wang Y.
europepmc   +1 more source

Factors influencing disease-free survival after radical endometrial cancer surgery: an analysis of the competitive risk prediction mode. [PDF]

Am J Transl Res
Cao X, Fang J, Wei Y, Liang S.
europepmc   +1 more source

Ovarian Tumor Biomarkers: Correlation Between Tumor Type and Marker Expression, and Their Role in Guiding Therapeutic Strategies. [PDF]

Int J Mol Sci
Gawełczyk W, Soczyńska J, Muzyka A, Rydzek J, Majcherczyk K, Żołyniak M, Woźniak S.   +6 more
europepmc   +1 more source

Assessment of risk factors for high-grade cervical or endometrial lesions to triage women with AGC-FN: a retrospective study. [PDF]

BMC Womens Health
Xu S, Jiang T, Mao X, Cai L, Lin X, Tong Y, Dong B, Sun P.   +7 more
europepmc   +1 more source

CT-based radiomics model for noninvasive prediction of progression-free survival in high-grade serous ovarian carcinoma: a multicenter study incorporating preoperative and postoperative clinical factors. [PDF]

BMC Med Imaging
Yu X, Zhang Z, Zou Y, Wang C, Jiao J, Wang C, Yu H, Zhang S.   +7 more
europepmc   +1 more source

Study of Glutathione S-Transferase, Its Isoenzyme (Pi), and Tumor Markers (CA15-3, HE4) in Breast Carcinoma Patients (Before and After Treatment).

J Pharm Bioallied Sci
Hawale D, Abichandani L, Ambad R.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A clinical study of serum human epididymis protein 4 (HE4) in the diagnosis of pancreatic cancer

Indian Journal of Cancer, 2021
Background: Pancreatic cancer (PC) has poor early diagnosis rates due to its insidious onset. Since human epididymis protein 4 (HE4) is highly expressed in patients with PC, we assessed whether serum HE4 could be a marker for the detection 3 of PC ...
Weiqi Liu, Weiling Liu, Keng Lin, Yuhua Liu, Heng Hu, Lina Yang   +5 more
semanticscholar   +3 more sources